HealthDay - WEDNESDAY, May 18 (HealthDay News) -- The results of a first prostate-specific antigen (PSA) test for males between the ages of 44 and 50 can predict the risk of dying of prostate cancer within the next 25 to 30 years, according to a new study.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.